HITLAB, a leading organization dedicated to encouraging healthcare innovation, is pleased to share that Amy West, formerly at Novo Nordisk, will be joining the team as a Principal Director, Advisory Services. She also currently serves as the Chair of HITLAB’s Women’s Health Tech Initiative.
Amy brings extensive experience from Novo Nordisk, where she spearheaded strategic digital health and innovation initiatives as well as partnerships. Her industry leadership showcases a passionate commitment to using technology to improve patient outcomes, especially in women’s health.
John Hammitt, HITLAB’s Global Director, stated, “Amy’s digital health expertise and dedication to women’s health make her a vital addition to our leadership. We’re excited to see the impact she’ll have as we drive innovation and meaningful change in healthcare.”
Amy expressed her enthusiasm, saying, “I’m thrilled to join HITLAB, a pioneer in digital health innovation. Leading the Women’s Health Initiative aligns with my passion for improving healthcare outcomes for women through technology. I look forward to collaborating with HITLAB’s talented team to push healthcare boundaries, particularly in underserved areas.”
HITLAB’s expansion in digital health is further solidified by Amy’s appointment, underscoring the organization’s commitment to leadership and innovation. This significant step forward in HITLAB’s mission aims to transform healthcare through innovative technology and evidentiary research.
Amy will also be featured on this week’s Women’s Health Tech Wednesday (September 4th @ 12:30pm ET) Sign up here.
Bookings with me – Amy West – Outlook (mcas.ms)
About HITLAB
HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services to improve health delivery around the world.
At HITLAB, we believe technology and health can work together to improve the quality of health delivery and healthcare worldwide. We use rigorous research and evidence-based methods to identify the best digital health solutions for each of our partners.
